Stockscreener 앱 받기
91.78
8.16%
-8.255
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Glaukos stock touches 52-week low at $91.65 amid market shifts - Investing.com Australia
The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals - Yahoo Finance
Learn to Evaluate (GKOS) using the Charts - news.stocktradersdaily.com
Glaukos CFO Thurman Alex R. sells $162k in stock By Investing.com - Investing.com South Africa
Glaukos CFO Thurman Alex R. sells $162k in stock - Investing.com
Glaukos Corporation (NYSE:GKOS) Is Expected To Breakeven In The Near Future - simplywall.st
Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS) - Yahoo Finance
Primecap Management Co. CA Has $182.08 Million Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
First Week of May 16th Options Trading For Glaukos (GKOS) - Nasdaq
(GKOS) Trading Report - Stock Traders Daily
Glaukos, RadiusXR, and Topcon Healthcare Work to Advance Vision Testing - Medical Product Outsourcing
RadiusXR and Glaukos Announce a New Collaboration With Topcon Healthcare, Inc., and the Launch of Inspire - Vision Monday
Here's Why You Should Retain Glaukos Stock in Your Portfolio - MSN
Glaukos Licenses Iveena’s Investigational Keratoconus Therapy - Business Wire
Midday Stock Roundup: Xponential Fitness Plunges 38%, GEN Restaurant Group Up 10% - Orange County Business Journal
Glaukos Highlights Strategic Focus in 2024 Presentation - TipRanks
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution - 01Net
Glaukos, RadiusXR collaborate with Topcon Healthcare on vision testing platform - TipRanks
Glaukos Unveils Game-Changing Vision Diagnostic Wearable: First-Ever Platform for Glaucoma Testing - Stock Titan
Where are the Opportunities in (GKOS) - news.stocktradersdaily.com
US Bancorp DE Acquires 470 Shares of Glaukos Co. (NYSE:GKOS) - Defense World
Glaukos Co. (NYSE:GKOS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Glaukos Corp. to Host Earnings Call - ACCESS Newswire
289 Shares in Glaukos Co. (NYSE:GKOS) Bought by IFP Advisors Inc - Defense World
Bank of New York Mellon Corp Increases Holdings in Glaukos Co. (NYSE:GKOS) - Defense World
Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey
Glaukos, Tarsus, RxSight: Q4 Earnings Snapshot - Orange County Business Journal
Stifel maintains Buy on Glaukos stock, reiterates $175 target By Investing.com - Investing.com South Africa
Stifel maintains Buy on Glaukos stock, reiterates $175 target - Investing.com
Truist Financial Corp Sells 5,319 Shares of Glaukos Co. (NYSE:GKOS) - Defense World
7 Best Medical Technology Stocks To Buy According To Analysts - Insider Monkey
Glaukos CEO Makes a Multi-Million Dollar Stock Sale! - TipRanks
Glaukos director Mark Foley sells common stock for $2.5 million By Investing.com - Investing.com Australia
Glaukos director Mark Foley sells common stock for $2.5 million - Investing.com
GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock? - MSN
Glaukos Corporation (NYSE:GKOS) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
(GKOS) Investment Report - Stock Traders Daily
Glaukos Co. (NYSE:GKOS) Shares Sold by Taylor Frigon Capital Management LLC - MarketBeat
FDA accepts Glaukos application for Epioxa for keratoconus - MSN
CIBC Asset Management Inc Makes New Investment in Glaukos Co. (NYSE:GKOS) - Defense World
Needham & Company LLC Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock - MarketBeat
GLAUKOS Corp SEC 10-K Report - TradingView
FDA sets review date for Glaukos’ keratoconus drug By Investing.com - Investing.com Australia
GKOSGlaukos Corp Latest Stock News & Market Updates - StockTitan
FDA gives Glaukos ‘Day 74’ notice for Epioxa NDA to treat keratoconus - TipRanks
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today - Benzinga
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Benzinga India
Glaukos Announces FDA Acceptance Of NDA Submission For Epioxa(TM) -February 24, 2025 at 08:24 am EST - Marketscreener.com
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™ - BioSpace
FDA sets review date for Glaukos' keratoconus drug - Investing.com India
Glaukos's Corneal Disease Drug Accepted for FDA Review -February 24, 2025 at 07:33 am EST - Marketscreener.com
FDA sets review date for Glaukos' keratoconus drug By Investing.com - Investing.com South Africa
FDA sets review date for Glaukos’ keratoconus drug - Investing.com UK
Revolutionary Eye Treatment Advances: Can Glaukos Transform Keratoconus Care Without Surgery? - StockTitan
Van ECK Associates Corp Trims Position in Glaukos Co. (NYSE:GKOS) - Defense World
0.62%
0.92%
자본화:
|
볼륨(24시간):